[1] Cameron, J.S. (1999) Lupus Nephritis. Journal of American Society of Nephrology, 10, 413-424.
[2] Ward, M.M. (2010) Access to Care and the Incidence of End-Stage Renal Disease Due to Systemic Lupus Erythematosus. Journal of Rheumatology, 37, 1158-1163.
https://doi.org/10.3899/jrheum.091199
[3] Saxena, R., Mahajan, T. and Mohan, C. (2011) Lupus Nephritis: Current Update. Arthritis Research & Therapy, 13, 240.
https://doi.org/10.1186/ar3378
[4] Imran, T.F., Yick, F., Verma, S., Estiveme, C., Ogbonnaya-Odor, C., Iruvarudsothy, S., et al. (2016) Lupus Nephritis: An Update. Clinical and Experimental Nephrology, 20, 1-13.
https://doi.org/10.1007/s10157-015-1179-y
[5] Dhir, V., Aggarwal, A., Lawrence, A., Agarwal, V. and Misra, R. (2012) Long-Term Outcome of Lupus Nephritis in Asian Indians. Arthritis Care & Research (Hoboken), 64, 713-720.
https://doi.org/10.1002/acr.21597
[6] Alarcon, G.S. (2011) Multiethnic Lupus Cohorts: What Have They Taught Us? Clinical Rheumatology, 7, 3-6.
https://doi.org/10.1016/j.reuma.2010.11.001
[7] Tektonidou, M.G., Dasgupta, A. and Ward, M.M. (2016) Risk of End-Stage Renal Disease in Patients with Lupus Nephritis, 1971-2015. A Systematic Review and Bayesian Meta-Analysis. Arthritis & Rheumatology, 68, 1432-1441.
https://doi.org/10.1002/art.39594
[8] Faurschou, M., Dreyer, L., Kamper, A.-L., Starklint, H. and Jacobsen, S. (2010) Long-Term Mortality and Renal Outcome in a Cohort of 100 Patients with Lupus Nephritis. Arthritis Care & Research (Hoboken), 62, 873-880.
https://doi.org/10.1002/acr.20116
[9] Tesar, V. and Hruskova, Z. (2011) Treatment of Proliferative Lupus Nephritis: A Slowly Changing Landscape. Nature Reviews Nephrology, 7, 96-109.
https://doi.org/10.1038/nrneph.2010.170
[10] Uchida, K. and Nitta, K. (2012) Recent Advances in the Treatment of Lupus Nephritis. Clinical and Experimental Nephrology, 16, 202-213.
https://doi.org/10.1007/s10157-011-0556-4
[11] Airoldi, E.M. (2007) Getting Started in Probabilistic Graphical Models. PLOS Computational Biology, 3, e252.
https://doi.org/10.1371/journal.pcbi.0030252
[12] Nishi, S., Ubara, Y., Utsunomiya, Y., Okada, K., Obata, Y., Kai, H., et al. (2016) Evidence-Based Clinical Practice Guidelines for Nephrotic Syndrome. Clinical and Experimental Nephrology, 20, 342-370.
https://doi.org/10.1007/s10157-015-1216-x
[13] Lee, K.J. and Carlin, J.B. (2010) Multiple Imputation for Missing Data: Fully Conditional Specification versus Multivariate Normal Imputation. American Journal of Epidemiology, 171, 624-632.
https://doi.org/10.1093/aje/kwp425
[14] Churg, J. and Sobin, L. (1982) Renal Disease: Classification and Atlas of Glomerular Disease. Igaku-Shoin, Tokyo.
[15] Hahn, B.H., McMahon, M.A., Wilkinson, A., Wallace, W.D., Daikh, D.I., Fitzgerald, J.D., et al., American College of Rheumatology (2012) American College of Rheumatology Guidelines for Screening, Treatment , and Management of Lupus Nephritis. Arthritis Care &Research (Hoboken), 64, 797-808.
https://doi.org/10.1002/acr.21664
[16] Bono, L., Cameron, J.S. and Hicks, J.A. (1999) The Very Long-Term Prognosis and Complications of Lupus Nephritis and Its Treatment. QJM, 92, 211-218.
https://doi.org/10.1093/qjmed/92.4.211
[17] Levey, A.S., Lan, S.P., Corwin, H.L., Kasinath, B.S., Lachin, J., Neilson, E.G., et al. (1992) Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study. Results of Treatment with Prednisone and Short-Term Oral Cyclophosphamide. Annals of Internal Medicine, 116, 114-123.
https://doi.org/10.7326/0003-4819-116-2-114
[18] Fraenkel, L., MacKenzie, T., Joseph, L., Kashgarian, M., Hayslett, J.P. and Esdaile, J.M. (1994) Response to Treatment as a Predictor of Long-Term Outcome in Patients with Lupus Nephritis. The Journal of Rheumatology, 21, 2052-2057.
[19] Austin, H.A., Boumpas, D.T., Vaughan, E.M. and Balow, J.E. (1994) Predicting Renal Outcomes in Severe Lupus Nephritis: Contributions of Clinical and Histologic Data. Kidney International, 45, 544-550.
https://doi.org/10.1038/ki.1994.70
[20] Austin, H.A., Boumpas, D.T., Vaughan, E.M. and Balow, J.E. (1995) High-Risk Features of Lupus Nephritis: Importance of Race and Clinical and Histological Factors in 166 Patients. Nephrology, Dialysis, Transplantation, 10, 1620-1628.
[21] Houssiau, F.A., Vasconcelos, C., D’Cruz, D., Sebastiani, G.D., de Ramon Garrido, E., Danieli, M.G., et al. (2004) Early Response to Immunosuppressive Therapy Predicts Good Renal Outcome in Lupus Nephritis: Lessons from Long-Term Followup of Patients in the Euro-Lupus Nephritis Trial. Arthritis & Rheumatology, 50, 3934-3940.
https://doi.org/10.1002/art.20666